| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/13/2008 | EP1335747B1 A composition of sodium channel blocking compound |
| 02/13/2008 | EP1313703B1 Prodrugs to nmda receptor ligands |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | EP1233770B1 Phosphonate compounds |
| 02/13/2008 | EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |
| 02/13/2008 | EP0909132B2 Dietetic baby food formula containing conjugated linoleic acids |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN101121013A Medicine for treating intractable oral cavity ulcer, Baiser's disease and sjogren syndrome and manufacturing method |
| 02/13/2008 | CN101120921A Target preparation consisting of liposome and nucleic acid coating contrast agent |
| 02/13/2008 | CN101120758A Liquid acidifier and preparation method |
| 02/13/2008 | CN100368431C Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors |
| 02/13/2008 | CN100368415C 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368410C Micronized crystalline tiotropium bromide |
| 02/13/2008 | CN100368401C Cyanoguanidine prodrugs |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/13/2008 | CN100368397C Prodrugs to d-prolines |
| 02/13/2008 | CN100368381C Tetra-(alpha-amino-acid or dipeptide) complexes of di-copper and synthetic method, and SOD loke activity |
| 02/13/2008 | CN100368020C Compositions for stimulating cytokine secretion and inducing an immune response |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/13/2008 | CN100367960C Process for producing coated preparation |
| 02/13/2008 | CN100367948C Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
| 02/13/2008 | CN100367866C Method for preparing kidney-warming face-beautifying soybean milk powder with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 02/13/2008 | CN100367865C Method for preparing digestion-promoting spleen-invigorating soybean milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
| 02/13/2008 | CN100367863C Method for preparing kidney-warming face-beautifying yoghourt with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329761 Substituted imides |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329728 Ligand activated transcriptional regulator proteins |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329676 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329663 Substituted-triazolopyrimidines as anticancer agents |
| 02/12/2008 | US7329661 N-phenyl-3-pyrimidine-amine derivatives |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 02/12/2008 | US7329541 Zinc finger binding domains for GNN |
| 02/12/2008 | US7329507 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329423 Compositions comprising thylakoids useful in the modulation of inflammation process |
| 02/12/2008 | US7329415 Bulking composite comprising liposomes stabilized by a shell of polyelectrolytes, with charging surface and opposite charging on underlayer; for use in biomedical drug delivery, in vivo detectors, and gene therapy, ophthalmic lens |
| 02/12/2008 | CA2496623C Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives |
| 02/12/2008 | CA2416823C Antimycotic nail varnish composition |
| 02/12/2008 | CA2411577C Stabiliser for radiopharmaceuticals |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2367909C Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response |
| 02/12/2008 | CA2303447C Cationic polymers as toxin-binding agents |
| 02/12/2008 | CA2294582C Treatment of diabetes with thiazolidinedione and metformin |
| 02/12/2008 | CA2290992C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 02/12/2008 | CA2208672C Immunotherapeutic imides/amides and their use for reducing levels of tnf.alpha. |
| 02/12/2008 | CA2172778C Cgrp antagonist used for the treatment of lichen and pruritus; composition thus produced |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/07/2008 | WO2008016665A2 Imidazoacridine compounds for treating flt3 -mediated disorders |
| 02/07/2008 | WO2008016431A2 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016171A1 Prophylactic/therapeutic agent for renal dysfunction |
| 02/07/2008 | WO2008016139A1 Fluorescent oleamide derivative and use thereof |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008016107A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 02/07/2008 | WO2008016077A1 Adhesive preparation |
| 02/07/2008 | WO2008016016A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008016002A1 AMYLOID β PRODUCTION REGULATOR CONTAINING PROTON PUMP INHIBITOR |
| 02/07/2008 | WO2008015950A1 Acat inhibitor |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |
| 02/07/2008 | WO2008015841A1 Kinase-inhibiting fused protein and pharmaceutical composition |
| 02/07/2008 | WO2008015794A1 Boronated quinazoline derivative |
| 02/07/2008 | WO2007124734A3 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/07/2008 | WO2007117398B1 Non-peptidic molecules for detecting and treating tumors |
| 02/07/2008 | US20080033392 Gelled composite |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033046 Treatment of myocardial infarction with 11HSD1 inhibitors |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033028 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis |
| 02/07/2008 | US20080033015 Histone Deacetylase Inhibitors |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/07/2008 | US20080032972 Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors |